Μάλτα - Αγγλικά - Medicines Authority

accord healthcare limited - furosemide - solution for injection - furosemide 10 mg/ml - diuretics

Μάλτα - Αγγλικά - Medicines Authority

accord healthcare limited - furosemide - solution for injection - furosemide 10 mg/ml - diuretics

Μάλτα - Αγγλικά - Medicines Authority

accord healthcare limited - furosemide - solution for injection - furosemide 10 mg/ml - diuretics

Μάλτα - Αγγλικά - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - furosemide - solution for infusion or injection - furosemide 10 mg/ml - diuretics

Μάλτα - Αγγλικά - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - furosemide - solution for infusion or injection - furosemide 10 mg/ml - diuretics

Μάλτα - Αγγλικά - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - furosemide - solution for infusion or injection - furosemide 10 mg/ml - diuretics

Μάλτα - Αγγλικά - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - furosemide - solution for infusion or injection - furosemide 10 mg/ml - diuretics

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

claris lifesciences (uk) limited - furosemide - solution for injection - 10 mg/ml - sulfonamides, plain

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - ondansetron hydrochloride dihydrate - solution for injection/infusion in pre-filled syringe - 2 milligram(s)/millilitre - ondansetron

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - furosemide 10 mg/ml; furosemide 10 mg/ml - oral solution - 10 mg/ml - active: furosemide 10 mg/ml excipient: butylated hydroxyanisole butylated hydroxytoluene ethanol glycerol methyl hydroxybenzoate orange flavour 987431 polysorbate 80 potassium sorbate quinoline yellow sodium hydroxide sorbitol water active: furosemide 10 mg/ml excipient: ethanol glycerol methyl hydroxybenzoate orange flavour propyl hydroxybenzoate purified water quinoline yellow sodium hydroxide sorbitol sunset yellow fcf - oedema lasix is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. lasix is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired. parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. lasix injection is also indicated as adjunctive therapy in acute pulmonary oedema and cerebral oedema where intense and rapid onset of diuresis is desired. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, lasix is indicated by the intravenous route. parenteral use should be replaced with oral lasix as soon as practical.